![[Website of the National Cancer Institute's Technology Transfer Center. Partnering with Industry for Improved Public Health.]](/images/template/spacer.gif)
Technology Transfer Center (TTC) of the National Cancer Institute makes it easy for industry and academia to interact and partner with National Institutes of Health laboratories and scientists. To learn more background information about TTC, choose from the following:
For information about cancer, clinical trials and statistics, please visit http://cancer.gov.
Uses of Cyanovirin-N for Anti-Hiv and Anti-Influenza Therapeutics and Prophylactics
T Cell Receptors that Recognize the Tyrosinase Tumor Antigen
Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12
TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.